Literature DB >> 6746859

Origin of plasma androstanediol glucuronide in men.

E Moghissi, F Ablan, R Horton.   

Abstract

The role of testosterone (T) and dihydrotestosterone (DHT) as precursors of the peripheral metabolite androstanediol glucuronide (3 alpha diol G) in plasma from normal men was studied. An apparent steady state of both putative precursors and the steroid glucuronides were attained by 8-h constant iv infusions of 3H-labeled steroid after a loading dose. The unconjugated steroids and the steroid glucuronides (after beta-glucuronidase hydrolysis) with 14C indicator were purified by serial microcolumn and paper chromatography steps previously reported to achieve radiochemical purity. The specific activities of 3 alpha diol and 3 alpha diol G in plasma were widely different in each subject, confirming our earlier suggestion that the two peripheral metabolites are formed in different pools. The conversion ratios (CRPre-Prod BB) varied widely. The CRT-3 alpha diol G was generally less than 5%, while the CRDHT-3 alpha diol G was 10 times higher. These results are compatible with the expected model, T----DHT----3 alpha diol G. In some of the studies, T glucuronide (TG) and DHT glucuronide (DHTG) were isolated after T infusions, and DHTG was isolated after DHT infusion. The major conversion product of blood T was DHTG, not TG, and the major conversion product of DHT was 3 alpha diol G. This suggests that metabolism proceeds through a steroid reduction step and glucuronidation. The peripheral pathway to 3 alpha diol G may involve formation of DHTG and then 3 alpha-reduction to 3 alpha diol G. This may also explain why blood levels of unconjugated 3 alpha diol have not been helpful in elucidating disorders of androgen formation, as this androgen mostly arises from sites different from 3 alpha diol G.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6746859     DOI: 10.1210/jcem-59-3-417

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

1.  Developmental patterns of serum 3 alpha-androstanediol glucuronide.

Authors:  H L Rittner; P D Lee; W F Blum; H G Doerr; J Steiss; J Kreuder; W Rascher; W Kiess
Journal:  J Endocrinol Invest       Date:  1997-05       Impact factor: 4.256

2.  Developmental patterns of serum 3 alpha-androstanediol glucuronide.

Authors:  H L Rittner; P D Lee; W F Blum; H G Doerr; J Steiss; J Kreuder; W Rascher; W Kiess
Journal:  J Endocrinol Invest       Date:  1997-03       Impact factor: 4.256

Review 3.  Combination therapy in stage C and D prostatic cancer: rationale and five year clinical experience.

Authors:  F Labrie; A Dupont; A Bélanger; L Cusan; M Giguère; Y Lacourcière; I Luthy; D Bégin; C Labrie; J Simard
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 4.  DHEA and the skeleton (through the ages).

Authors:  C M Gordon; J Glowacki; M S LeBoff
Journal:  Endocrine       Date:  1999-08       Impact factor: 3.633

Review 5.  The steroid metabolome of adrenarche.

Authors:  Juilee Rege; William E Rainey
Journal:  J Endocrinol       Date:  2012-06-19       Impact factor: 4.286

Review 6.  Pharmacology and therapeutic effects of dehydroepiandrosterone in older subjects.

Authors:  Sylvie Legrain; Laurence Girard
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

7.  Plasma 3 alpha-androstanediol glucuronide in precocious adrenarche.

Authors:  R Balducci; G Finocchi; A Mangiantini; P Bianchi; R Guglielmi; V Toscano
Journal:  J Endocrinol Invest       Date:  1993-02       Impact factor: 4.256

8.  Circulating dihydrotestosterone may not reflect peripheral formation.

Authors:  V Toscano; R Horton
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

Review 9.  Might DHEA be considered a beneficial replacement therapy in the elderly?

Authors:  Alessandro D Genazzani; Chiara Lanzoni; Andrea R Genazzani
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

10.  Androgen activity and markers of inflammation among men in NHANES III.

Authors:  C Mary Schooling
Journal:  Am J Hum Biol       Date:  2013-08-13       Impact factor: 1.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.